Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I data presented on SBI-087 in RA and SLE

July 12, 2010

Ardea describes next-generation URAT-1 inhibitor RDEA-684

July 12, 2010

Clinical trials show potential of ASP-1941 to treat type 2 diabetes

July 12, 2010

Sanwa describes preclinical pharmacology of SKL-18287 and SKL-19014

July 12, 2010

TEAMSTA trial data support efficacy of telmisartan/amlodipine combination

July 12, 2010

Evatanepag accelerates fracture healing in phase II trial

July 9, 2010

TRUST trial further explores efficacy and safety of corifollitropin alfa

July 9, 2010

UDPGT 1-4 gene polymorphism affects lamotrigine pharmacokinetics

July 9, 2010

Aliskiren/amlodipine combination effective in hypertension

July 9, 2010

Intratumoral TG-4023 gene therapy is feasible in patients with liver cancer

July 9, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...